Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Use of Superlatives in Cancer Research

The Use of Superlatives in Cancer Research This investigation of recent news coverage of cancer research found that although most new cancer drugs offer only modest benefits, they are often described in the news media with superlatives, such as “revolutionary” and “game changer,” that may be unwarranted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

The Use of Superlatives in Cancer Research

Abola, Matthew V.; Prasad, Vinay
JAMA Oncology , Volume 2 (1) – Jan 1, 2016
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/the-use-of-superlatives-in-cancer-research-E3FeFFRzTI

References (10)

  • J. Unger, D. Hershman, K. Albain, C. Moinpour, J. Petersen, K. Burg, J. Crowley (2013)

    Patient income level and cancer clinical trial participation.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 5

  • D. Church, S. Briggs, C. Palles, E. Domingo, S. Kearsey, J. Grimes, M. Gorman, Lynn Martin, K. Howarth, S. Hodgson, K. Kaur, Jenny Taylor, I. Tomlinson (2013)

    DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer

    Human Molecular Genetics, 22

  • T. Fojo, S. Mailankody, A. Lo (2014)

    Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

    JAMA otolaryngology-- head & neck surgery, 140 12

  • Douglas Levine, Gad L, G. Getz, S. Gabriel, K. Cibulskis, Eric Lander, A. Sivachenko, C. Sougnez, Mike Lawrence, C. Kandoth, D. Dooling, Robert Fulton, L. Fulton, Joelle Kalicki-Veizer, M. McLellan, M. O'Laughlin, Heather Schmidt, Richard Wilson, Kai Ye, Li-hua Ding, E. Mardis, Adrian Ally, M. Balasundaram, I. Birol, Y. Butterfield, R. Carlsen, Candace Carter, Andy Chu, E. Chuah, Hye-Jung Chun, Noreen Dhalla, R. Guin, Carrie Hirst, R. Holt, Steven Jones, D. Lee, H. Li, Marco Marra, Michael Mayo, Richard Moore, A. Mungall, Patrick Plettner, J. Schein, Payal Sipahimalani, Angela Tam, R. Varhol, A. Robertson, A. Cherniack, I. Pashtan, G. Saksena, R. Onofrio, S. Schumacher, B. Tabak, S. Carter, Bryan Hernandez, Jeff Gentry, H. Salvesen, K. Ardlie, W. Winckler, R. Beroukhim, M. Meyerson, Angela Hadjipanayis, Semin Lee, Harshad Mahadeshwar, Peter Park, A. Protopopov, X. Ren, S. Seth, Xingzhi Song, Jiabin Tang, Ruibin Xi, Lixing Yang, Dong Zeng, R. Kucherlapati, Lynda Chin, Jianhua Zhang, J. Auman, S. Balu, T. Bodenheimer, Elizabeth Buda, D. Hayes, A. Hoyle, S. Jefferys, Corbin Jones, S. Meng, Piotr Mieczkowski, Lisle Mose, Joel Parker, C. Perou, J. Roach, Yan Shi, J. Simons, Mathew Soloway, Donghui Tan, M. Topal, S. Waring, Junyuan Wu, K. Hoadley, S. Baylin, M. Bootwalla, Phillip Lai, Timothy Jr, David Berg, D. Weisenberger, Peter Laird, Hui Shen, Juok Cho, D. Dicara, S. Frazer, David Heiman, R. Jing, Pei Lin, Will Mallard, P. Stojanov, Douglas Voet, Hailei Zhang, L. Zou, M. Noble, Sheila Reynolds, I. Shmulevich, B. Aksoy, Yevgeniy Antipin, G. Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, A. Jacobsen, M. Ladanyi, B. Reva, C. Sander, Rileen Sinha, S. Sumer, Barry Taylor, E. Cerami, Nils Weinhold, N. Schultz, R. Shen, Stephen Benz, Ted Goldstein, David Haussler, S. Ng, Christopher Szeto, Joshua Stuart, Christopher Benz, C. Yau, Wei Zhang, M. Annala, B. Broom, Tod Casasent, Z. Ju, Han Liang, Guoyan Liu, Yiling Lu, A. Unruh, Chris Wakefield, John Weinstein, Nianxiang Zhang, Yuexin Liu, R. Broaddus, R. Akbani, Gordon Mills, Christopher Adams, T. Barr, Aaron Black, Jay Bowen, John Deardurff, J. Frick, J. Gastier-Foster, T. Grossman, Hollie Harper, Melissa Hart-Kothari, Carmen Helsel, Aaron Hobensack, Harkness Kuck, K. Kneile, K. Leraas, T. Lichtenberg, Cynthia McAllister, R. Pyatt, N. Ramirez, Teresa Tabler, Nathan Vanhoose, Peter White, L. Wise, E. Zmuda, N. Barnabas, Charlenia Berry-Green, Victoria Blanc, L. Boice, Michael Button, Adam Farkas, Alex Green, Jean MacKenzie, Dana Nicholson, S. Kalloger, C. Gilks, B. Karlan, J. Lester, S. Orsulic, M. Borowsky, Mark Cadungog, Christine Czerwinski, L. Huelsenbeck-Dill, M. Iacocca, N. Petrelli, B. Rabeno, G. Witkin, Elena Nemirovich-Danchenko, O. Potapova, D. Rotin, Andrew Berchuck, M. Birrer, Phillip DiSaia, L. Monovich, Erin Curley, J. Gardner, D. Mallery, R. Penny, S. Dowdy, B. Winterhoff, Linda Dao, B. Gostout, A. Meuter, Attila Teoman, F. Dao, Narciso Olvera, F. Bogomolniy, K. Garg, R. Soslow, Douglas Levine, Mikhail Abramov, John Bartlett, S. Kodeeswaran, J. Parfitt, Fedor Moiseenko, B. Clarke, Marc Goodman, M. Carney, R. Matsuno, J. Fisher, Mei Huang, W. Rathmell, L. Thorne, L. Le, R. Dhir, Robert Edwards, E. Elishaev, Kristin Zorn, P. Goodfellow, D. Mutch, A. Kahn, Daphne Bell, Pamela Pollock, Chen Wang, David A.Wheeler, E. Shinbrot, Brenda Ayala, A. Chu, Mark Jensen, Prachi Kothiyal, T. Pihl, Joan Pontius, D. Pot, Eric Snyder, Deepak Srinivasan, Kenna Shaw, Margi Sheth, Tanja Davidsen, Greg Ferguson, John Demchok, Liming Yang, M. Guyer, B. Ozenberger, H. Sofia (2013)

    Integrated genomic characterization of endometrial carcinoma

    Nature, 497

  • L. Ellis, C. Blanke, N. Roach (2015)

    Losing "Losing the Battle With Cancer".

    JAMA oncology, 1 1

  • I. Gool, F. Eggink, Luke Freeman-Mills, E. Stelloo, E. Marchi, M. Bruyn, C. Palles, R. Nout, C. Kroon, E. Osse, P. Klenerman, C. Creutzberg, I. Tomlinson, V. Smit, H. Nijman, T. Bosse, D. Church (2015)

    POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

    Clinical Cancer Research, 21

  • D. Church, E. Stelloo, R. Nout, N. Valtcheva, Jeroen Depreeuw, N. Haar, A. Noske, F. Amant, I. Tomlinson, P. Wild, D. Lambrechts, I. Jürgenliemk-Schulz, J. Jobsen, V. Smit, C. Creutzberg, T. Bosse (2014)

    Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

    JNCI Journal of the National Cancer Institute, 107

  • B. Howitt, S. Shukla, L. Sholl, Lauren Ritterhouse, J. Watkins, S. Rodig, E. Stover, K. Strickland, A. D’Andrea, Catherine Wu, U. Matulonis, P. Konstantinopoulos (2015)

    Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.

    JAMA oncology, 1 9

  • S. Dentzer (2009)

    Communicating medical news--pitfalls of health care journalism.

    The New England journal of medicine, 360 1

  • E. Horstmann, M. McCabe, L. Grochow, Seiichiro Yamamoto, L. Rubinstein, T. Budd, D. Shoemaker, E. Emanuel, C. Grady (2005)

    Risks and benefits of phase 1 oncology trials, 1991 through 2002.

    The New England journal of medicine, 352 9

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2015.3931
pmid
26512913
Publisher site
See Article on Publisher Site

Abstract

This investigation of recent news coverage of cancer research found that although most new cancer drugs offer only modest benefits, they are often described in the news media with superlatives, such as “revolutionary” and “game changer,” that may be unwarranted.

Journal

JAMA Oncology – American Medical Association

Published: Jan 1, 2016

There are no references for this article.